The global degenerative disc disease treatment market size reached US$ 26.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.3% during 2023-2028. The rising prevalence of degenerative disc disease among the masses, the growing geriatric population, and the adoption of digital health solutions in degenerative disc disease management represent some of the key factors driving the market.
|Market Size in 2022
||US$ 26.7 Billion
|Market Forecast in 2028
||US$ 40.9 Billion
|Market Growth Rate (2023-2028)
Degenerative disc disease (DDD) is the gradual breakdown of intervertebral discs in the spine, often causing pain, stiffness, and reduced mobility. Degenerative disc disease treatment includes various treatment options that aim to manage symptoms and improve quality of life. It includes several non-surgical treatments, such as physical therapy, which focuses on strengthening the surrounding muscles, improving flexibility, and promoting proper spinal alignment. Additionally, DDD involves the use of pain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or muscle relaxants that can provide relief by reducing inflammation and easing discomfort. Besides, maintaining a healthy weight and engaging in regular exercise can help reduce stress on the spine and improve overall spinal health. Applying heat or cold packs to the affected area also offers temporary relief. In addition, lifestyle modifications, such as maintaining good posture during activities and avoiding activities that place excessive strain on the spine, are also crucial in the long-term management of DDD.
Degenerative Disc Disease Treatment Market Trends:
The rising prevalence of degenerative disc disease among individuals is driving the global market. This can be attributed to several factors, such as sedentary lifestyles, poor posture, rising rates of obesity, and a growing geriatric population. Moreover, increasing awareness and diagnosis rates contribute to the augmenting demand for DDD treatment. Furthermore, continual advancements in diagnostic techniques, such as advanced imaging technologies that aid in the accurate and timely detection of DDD, are providing a boost to the overall demand. Besides, the widespread availability of advanced healthcare infrastructure, such as well-equipped hospitals, specialized clinics, and skilled healthcare professionals, is acting as another growth-inducing factor. Furthermore, several major companies are heavily investing in extensive research and development activities to develop innovative therapies, drugs, and technologies, are creating a positive market outlook. Besides, the growing educational initiatives by healthcare providers, patient advocacy groups, and online resources provide information on DDD symptoms, treatment options, and self-management strategies are impacting the market favorably. The market is further driven by rising government initiatives aimed at improving healthcare infrastructure and providing accessible healthcare services. Moreover, the rising adoption of digital health solutions in DDD management is augmenting the market as these technologies improve accessibility to healthcare services, enable remote consultations, enhance patient engagement, and facilitate personalized treatment plans. Other factors, such as the increasing preference for minimally invasive procedures and increasing awareness of regenerative medicine, are also influencing the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global degenerative disc disease treatment market report, along with forecasts at the global, regional, and country levels for 2023-2028. Our report has categorized the market based on product type and end user.
Product Type Insights:
- Oral steroids
- Muscle Relaxants
- Cervical Spine
- Lumbar Spine
- Thoracic Spine
- Spinal Fusion
A detailed breakup and analysis of the degenerative disc disease treatment market based on the product type has also been provided in the report. This includes drugs (acetaminophen, NSAIDs, oral steroids, and muscle relaxants) and devices (cervical spine, lumbar spine, thoracic spine and spinal fusion). According to the report, devices exhibited a clear dominance in the market.
End User Insights:
- Ambulatory Surgical Centers
- Orthopedic Center
A detailed breakup and analysis of the degenerative disc disease treatment market based on the end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and orthopedic center. According to the report, hospitals exhibited a clear dominance in the market.
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America exhibited a clear dominance in the market. Some of the factors driving the North America degenerative disc disease treatment market included increasing demand for minimally invasive procedures, the rising government initiatives aimed at improving healthcare infrastructure, and growing educational initiatives by healthcare providers.
The report has also provided a comprehensive analysis of the competitive landscape in the global degenerative disc disease treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, DiscGenics Inc., Medtronic Plc, NuVasive Inc, Orthofix US LLC, Spinal Simplicity LLC, Spine BioPharma LLC, Spine Wave Inc, Zavation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
| Historical Period
|Scope of the Report
||Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Product Type
- End User
|Product Types Covered
- Drugs: Acetaminophen, NSAIDs. Oral steroids, Muscle Relaxants
- Devices: Cervical Spine, Lumbar Spine, Thoracic Spine, Spinal Fusion
| End Users Covered
||Hospitals, Ambulatory Surgical Centers, Orthopedic Center
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||B. Braun Melsungen AG, DiscGenics Inc., Medtronic Plc, NuVasive Inc, Orthofix US LLC, Spinal Simplicity LLC, Spine BioPharma LLC, Spine Wave Inc, Zavation, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global degenerative disc disease treatment market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global degenerative disc disease treatment market?
- What is the impact of each driver, restraint, and opportunity on the global degenerative disc disease treatment market?
- What are the key regional markets?
- Which countries represent the most attractive degenerative disc disease treatment market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the degenerative disc disease treatment market?
- What is the breakup of the market based on the end-user?
- Which is the most attractive end-user in the degenerative disc disease treatment market?
- What is the competitive structure of the global degenerative disc disease treatment market?
- Who are the key players/companies in the global degenerative disc disease treatment market?
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the degenerative disc disease treatment market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global degenerative disc disease treatment market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the degenerative disc disease industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.